WILLIAM HUGHES PERANTEAU, M.D.

Plain English
This study examined the occurrence of seromas, which are fluid-filled sacs, in mothers after they underwent surgery to correct fetal neural tube defects. Out of 330 women, 37% developed a seroma, typically diagnosed about 11 days after surgery, but most were small and resolved on their own within three weeks. Important findings included that older mothers and those with higher body mass index were more likely to develop seromas; however, this did not affect overall surgical outcomes or complications for the mothers or babies. Who this helps: This information benefits patients and their doctors by providing insight into potential risks following this surgery.

Plain English
This study looked at how treating severe congenital diaphragmatic hernia (CDH) with a technique called fetoscopic endoluminal tracheal occlusion (FETO) compared to standard care without this treatment affected early childhood outcomes. It found that 91% of infants treated with FETO survived to age 2, compared to 75% of those who didn’t have the procedure. Importantly, none of the FETO patients needed medication for lung-related high blood pressure, while 22% of non-FETO patients did, suggesting FETO may lead to better health outcomes in the long term. Who this helps: This helps infants born with severe CDH and their families.

Plain English
This study looked at babies born with multiple lung problems called congenital thoracic lesions (CTL), analyzing data from 701 patients over about a decade. They found that about 10.5% of these patients had multiple CTL, with most cases being on the right side of the lung. The study also noted that many of these cases went undetected before birth, highlighting the importance of better prenatal screening and genetic testing, as some patients had additional congenital issues. Who this helps: Patients with congenital lung conditions and their families.

Plain English
This study focused on improving the delivery of mRNA-based therapies, which can potentially cure diseases by editing genes. Researchers created a new method to assemble biodegradable lipids that package mRNA more effectively, leading to better delivery results. They found that their best lipid candidate significantly enhanced the performance of lipid nanoparticles used for gene editing. Who this helps: This benefits patients needing gene therapies, as well as doctors involved in genetic treatments.

Plain English
This study looked at how different testing methods can help diagnose craniofacial fibrous dysplasia (FD), a benign bone tumor that can cause facial deformity and other serious issues. The researchers examined 6 patients and found that while 4 were diagnosed with FD, 1 had a different condition, and 1 had a blood vessel issue. They discovered harmful genetic changes in the cells of all patients that could help explain the disease's complexity, with genetic variants found in about 36% to 50% of the abnormal bone and cultured cells. Who this helps: This benefits patients with craniofacial fibrous dysplasia by improving diagnosis and understanding of their condition.

Plain English
This study looked at a treatment called fetoscopic endoluminal tracheal occlusion (FETO) for babies with a serious condition known as congenital diaphragmatic hernia (CDH). It found that 91.7% of babies who received FETO survived, compared to 71.4% of those who were managed without this treatment. However, FETO also had risks, such as a higher chance of complications for the mother and earlier delivery. Who this helps: This research benefits pregnant women facing severe CDH in their babies and the healthcare providers caring for them.

Plain English
This study focused on improving a gene-editing treatment for genetic disorders like phenylketonuria (PKU) and pseudoxanthoma elasticum (PXE). Researchers found that using modified guide RNAs (called hybrid gRNAs) significantly reduced unwanted changes to other genes—by 90%—while effectively targeting the desired genes. This advancement could make gene-editing therapies safer and more effective for patients with these genetic conditions. Who this helps: This helps patients with PKU, PXE, and hereditary tyrosinemia type 1.

Plain English
This study looked at new ways to treat genetic disorders like phenylketonuria (PKU), pseudoxanthoma elasticum (PXE), and hereditary tyrosinemia type 1 (HT1) using a method called adenine base editing. Researchers tested hybrid guide RNAs (gRNAs) that resulted in nearly zero harmful side effects, allowing for precise corrections of gene mutations in lab models, which improved treatment effectiveness by significantly reducing unwanted changes to DNA. This is important because it makes gene editing therapies safer and more reliable for patients with these genetic disorders. Who this helps: Patients with PKU, PXE, and HT1.

Plain English
This study looks at how fetal gene therapy has developed since its early proposals in the late 1990s, tracking progress in diagnosing and treating genetic diseases before birth. Researchers highlight that advancements in fetal surgery and diagnosis are making it possible to treat several inherited conditions earlier than ever, with ongoing clinical trials paving the way for effective therapies. This matters because treating genetic diseases before birth can lead to better health outcomes for infants and families. Who this helps: This helps patients with genetic disorders and their families.

Plain English
This study examined the deaths of young people (aged 26 and under) caused by interactions with law enforcement between 2003 and 2018. Researchers found that, out of 1,281 young decedents, a very high 92.5% were classified as involved in violence, but Black youths were less likely to be armed or involved in violent crimes compared to White youths. However, Black youths faced more justified uses of lethal force and were more often stopped by police for non-violent reasons like traffic stops, highlighting a troubling racial disparity in these incidents. Who this helps: This helps policymakers and advocacy groups working to address racial inequalities in law enforcement practices.

Plain English
This study looked at how infants with a severe lung condition called congenital diaphragmatic hernia (CDH) are resuscitated after birth, especially those treated with a procedure called fetoscopic endoluminal tracheal occlusion (FETO). Researchers found that infants who received FETO had a higher survival rate of 92% compared to 60% for those who received standard treatment, and they often needed less use of life support machines. The findings suggest that FETO is a beneficial option for these infants when done at experienced medical centers, emphasizing the importance of a skilled medical team for their care. Who this helps: This helps infants with congenital diaphragmatic hernia and their families.

Plain English
This study looked at a new treatment approach for serious blood disorders like sickle cell disease by performing a type of transplant before birth in mice. Researchers found that using a specific immune-modulating drug allowed the transplanted cells to integrate and work without being rejected, achieving this in 100% of cases studied. This method could improve transplantation success rates in fetuses and make it possible to treat blood disorders earlier in development. Who this helps: This helps patients with blood disorders, especially those receiving prenatal care.

Plain English
This study looked at how to improve the delivery of gene editing tools using tiny fat particles called lipid nanoparticles (LNPs). Researchers found that by optimizing the ingredients in these particles, they could achieve three times better gene editing results and reduce a harmful protein by the same amount compared to earlier versions that weren’t optimized. This is important because it could lead to more effective treatments for genetic diseases like metabolic disorders. Who this helps: This helps patients with genetic diseases.

Plain English
Researchers studied how a mother's existing immune response to specific viruses and proteins affects the success of gene editing in unborn mice. They found that if a mother had antibodies against the adeno-associated virus (AAV), it could hinder the gene editing procedure in her fetus, especially when these antibodies were present in higher amounts. The presence of these antibodies was less of a concern during early pregnancy, indicating a potential time for more effective gene editing before birth. Who this helps: Patients with genetic diseases that could benefit from in utero gene editing therapies.

Plain English
This study investigated a new way to deliver gene editing tools to blood-forming stem cells in fetuses to treat genetic blood disorders. Researchers created special particles that can target these stem cells and found that after a single injection into pregnant mice, the gene editing was effective and long-lasting. These findings are important because they show a potential method to treat serious genetic diseases before birth, improving outcomes for affected children. Who this helps: This benefits patients with genetic blood disorders and their families.

Plain English
This research studied how proteins are produced and broken down in different tissues of developing mouse embryos. The researchers injected specific amino acids into pregnant mice and found that protein turnover rates varied from 0.0000381 to 0.424 hours across different organs, indicating that some organs, like the liver and brain, have similar protein production rates but differ significantly in how quickly they turnover proteins. Understanding these dynamics is important because they help researchers know how fetus organs develop properly. Who this helps: This helps scientists and medical professionals studying fetal development and related health issues.

Plain English
This study examined different types of congenital pulmonary airway malformations (CPAMs) in the lungs to understand their causes and characteristics. Researchers found that type 1 and 3 CPAMs are linked to specific gene mutations (KRAS), while type 2 CPAMs and lung sequestrations seem to arise from airway blockages instead, with 100% of type 2 cases tested negative for KRAS mutations. By identifying these distinct causes, the findings could lead to better ways to classify and treat these lung conditions. Who this helps: This helps doctors in diagnosing and managing congenital lung malformations effectively.

Plain English
This research paper looks at how gene editing can be used to treat genetic diseases in unborn babies before they develop serious health problems. The findings show promising results for using gene editing in the womb, suggesting that it could effectively treat issues in organs such as the liver and lungs. This is important because it could lead to effective one-time treatments that prevent these diseases from harming the baby before and after birth. Who this helps: This benefits unborn babies with genetic conditions and their families.

Plain English
Researchers studied a condition called VACTERL, which involves the presence of several congenital defects in newborns. Out of over 11 million neonates, 1,886 (0.016%) had VACTERL, with 12.7% dying before leaving the hospital, particularly those with certain factors like limb anomalies or low birth weight. The study created a new assessment tool to help doctors provide better guidance to families about the risks and expected outcomes associated with VACTERL. Who this helps: This helps expectant families and healthcare providers.

Plain English
This study looked at a new type of delivery system called ionizable lipid nanoparticles (LNPs) to transport mRNA treatments to the brains of newborn mice, which could help with congenital brain diseases. Researchers found that a particular LNP (called C3 LNP) delivered mRNA more effectively than a standard product approved by the FDA and was able to improve symptoms of a specific brain disease in newborn mice. This is important because it shows the potential for these LNPs to be used in real treatments for human brain diseases, particularly through gene editing. Who this helps: Patients with congenital brain diseases and medical professionals working on innovative treatments.

Plain English
This research focused on phenylketonuria (PKU), a genetic disorder that causes harmful levels of a substance called phenylalanine in the blood. The study found that using a precise gene-editing technique, researchers were able to completely normalize blood phenylalanine levels in mice with a common PKU variant within just 48 hours after treatment. This breakthrough could lead to a new, effective treatment option for some patients with PKU, instead of relying on long-term dietary restrictions. Who this helps: This helps patients with phenylketonuria and their families.

Plain English
This study looked at how different surgical methods for removing large lung tumors in unborn babies affect health outcomes. Researchers analyzed data from 85 patients and found that the surgery type (either before birth, during delivery, or immediately after cesarean) did not significantly change survival rates or length of hospital stays, indicating similar effectiveness across methods. The study highlights that using maternal medication and adjusting care strategies can improve outcomes for these high-risk pregnancies, making it crucial to adapt treatment plans accordingly. Who this helps: This helps doctors and healthcare providers make better decisions for pregnant patients facing these complications.

Plain English
This study looked at a treatment called in utero hematopoietic cell transplantation (IUHCT) for babies who have genetic blood disorders, like sickle cell disease. Researchers found that babies receiving this treatment were much less likely to develop graft-versus-host disease (GVHD) compared to newborns who had the same cells transplanted after birth. Specifically, they showed that this resistance was linked to higher levels of a substance called interleukin-10 in fetal blood, which helps regulate the immune response and prevent GVHD. Who this helps: This research benefits patients with congenital blood disorders and their families.

Plain English
This study looked at how proteins are made and broken down in mouse fetuses to understand their development better. The researchers found that, on average, about 17.5% of injected amino acids were incorporated into developing tissues, with protein turnover rates varying significantly across different organs. This information is important because it helps us understand how protein production affects the development of organs and could provide insights into preventing developmental problems. Who this helps: This helps researchers and doctors who study fetal development and related health issues.

Plain English
This study focused on developing a method to deliver messenger RNA (mRNA) to unborn babies to treat genetic disorders before they cause serious problems. Researchers created various lipid nanoparticles (LNPs) that remained stable in amniotic fluid and found that these LNPs successfully delivered mRNA to fetal cells, especially in the lungs. This is significant because it opens up new possibilities for treating congenital disorders before birth, potentially reducing illness and improving outcomes for many children. Who this helps: This benefits unborn patients with genetic disorders.

Plain English
This study looked at how caregivers and healthcare providers support infants with pulmonary hypoplasia (PH) as they receive enteral nutrition, which is a way of feeding that provides essential nutrients directly into the stomach. Researchers conducted interviews with 10 caregivers and 10 healthcare team members to identify challenges and helpful strategies during different stages of care, including the time in the neonatal intensive care unit (NICU) and after going home. They found that the relationship between caregivers and providers is crucial for helping families adapt, and addressing issues like uncertainty and training can lead to better growth and feeding management for these infants. Who this helps: This helps caregivers and healthcare providers working with infants with pulmonary hypoplasia.

Plain English
This study focused on a type of lung problem in newborns called congenital pulmonary airway malformations (CPAMs) that have mutations in a gene known as KRAS. Researchers looked at 61 samples and found that all had the same KRAS mutation, linking it to specific types of abnormal cells that might lead to cancer. This is important because it shows that these mutations are common in CPAMs and helps doctors understand how to treat these conditions better, emphasizing the need for complete removal of the affected tissue to prevent cancer risks. Who this helps: This benefits patients with CPAMs and their doctors by guiding treatment decisions.

Plain English
Researchers explored new treatments for genetic disorders that can be given to unborn babies. They found that methods like gene editing and stem cell therapy could effectively correct these disorders before any permanent damage occurs. This is important because it could lead to better health outcomes for babies who would otherwise face serious health issues. Who this helps: This benefits unborn babies with genetic disorders and their families.

Plain English
This research paper focuses on the methods used to deliver gene therapy to unborn babies to treat genetic disorders before they develop symptoms. The authors review both viral and non-viral methods for getting genetic material into cells and highlight the challenges of ensuring the delivery is safe and effective. This research is important as it opens up the possibility of treating a wide range of genetic conditions early, potentially improving health outcomes for affected infants. Who this helps: Patients with congenital genetic disorders and their families.

Plain English
This paper looks at gene therapy given to fetuses to address serious health issues before they are born. Researchers found that treating the fetus can be effective due to its small size and immune system, which is less likely to reject the therapy. However, there are many practical and social challenges that need to be overcome to make this type of treatment widely available. Who this helps: This helps patients and future parents facing serious genetic conditions in their unborn children.

Plain English
Researchers developed new ionizable lipid nanoparticles (LNPs) to deliver messenger RNA (mRNA) to mouse fetuses in order to treat genetic diseases before they become serious. They found that these LNPs effectively reached fetal organs like the liver, lungs, and intestines better than existing delivery systems, leading to successful production of therapeutic proteins. This advancement could allow for treatments that stop genetic diseases early in development, improving outcomes for affected children. Who this helps: This helps patients who might be born with genetic diseases, their families, and doctors involved in prenatal care.

Plain English
This study looked at a treatment method called in utero base editing to fix a genetic problem that causes Mucopolysaccharidosis type I (MPS-IH), a serious condition affecting many organs. The researchers found that using a specific virus to deliver the editing tool before birth corrected the genetic mutation in liver and heart cells and resulted in better survival rates and improved health, particularly for muscles and the heart. This treatment shows promise for improving outcomes for newborns with this lethal genetic disorder and could also help with other similar diseases. Who this helps: This benefits patients with MPS-IH and their families.

Plain English
This study investigated the use of gene therapy to treat metabolic disorders before a baby is born. Researchers found that using advanced techniques like CRISPR can successfully insert healthy genes into cells to replace defective ones, which is crucial for producing the necessary proteins the body needs. This matters because treating these disorders early can prevent serious health issues for the child after birth. Who this helps: Patients with metabolic disorders and their families.

Plain English
This study looked at how inhaled nitric oxide (iNO) helps some infants with congenital diaphragmatic hernia (CDH) and pulmonary hypertension (PH). Out of 131 patients analyzed, 95 were treated with iNO, and 40% of them showed significant improvement in their oxygen levels after treatment. This finding is important because it indicates that iNO can enhance oxygenation and reduce the need for more invasive treatments in certain infants with CDH who have normal heart function. Who this helps: This benefits infants with congenital diaphragmatic hernia and pulmonary hypertension, as well as their doctors.

Plain English
Researchers are studying gene therapy that can be applied before a baby is born, known as prenatal gene therapy. They found that this approach could address genetic diseases more effectively than treatments given after birth, especially since many problems start developing before a child is born. While animal studies show promise with no major negative effects on the mother or future generations, thoughtful ethical guidelines are necessary to ensure safety and to advise families properly. Who this helps: This helps expectant parents, doctors, and families facing genetic disorders.

Plain English
This study looked at a type of lung abnormality in infants called congenital pulmonary airway malformations (CPAMs) and found that many of them contain water-filled cell clusters that can look similar to cancerous cells in adults. Researchers analyzed 671 clusters from 44 infants and found that even though these clusters had features that might suggest cancer, infants who had surgery for CPAMs did not experience cancer recurrence. This is important because it reassures families that these clusters are not harmful and helps avoid unnecessary anxiety or misdiagnosis. Who this helps: This benefits infants with CPAMs and their families, as well as doctors who treat them.

Plain English
This research examined how gene and stem cell therapies could be used to treat certain disorders before birth, which may lead to better outcomes for babies. The study found that prenatal therapy shows promise, with advancements in methods and technology leading to successful applications in animal models and early human trials. This matters because treating conditions before birth can take advantage of factors unique to fetal development, potentially improving health at birth and beyond. Who this helps: This helps expectant parents and babies with specific medical conditions.

Plain English
This study looked at the occurrence of multiple congenital lung problems in newborns and how well these issues can be detected before birth using ultrasound and MRI. Out of 539 babies who had surgery for lung issues, 35 (or 6.5%) had more than one abnormality, and in almost 37% of cases, these issues were identified before birth. Recognizing these multiple conditions early can help doctors better prepare for treatment after the baby is born. Who this helps: This benefits expectant parents and healthcare providers who need to plan for the care of babies with complex lung conditions.

Plain English
This study looked at how a mother's weight (measured by Body Mass Index, or BMI) affects the outcomes of surgery done while pregnant to fix a serious spinal defect called myelomeningocele in unborn babies. Researchers analyzed data from 264 women and found that not only did women with higher BMIs (up to 40) have similar surgery and delivery outcomes as those with lower weights, but the surgery itself took longer for heavier women. This is important because it shows that heavier mothers can safely undergo this surgery without a higher risk of complications, widening the treatment options for them and their babies. Who this helps: Patients, especially pregnant women with higher BMI who are facing myelomeningocele surgery.

Plain English
This research paper outlines the American Thoracic Society's updated curriculum for pediatric lung health, focusing on various important topics like childhood respiratory failure and the use of e-cigarettes. Key issues discussed include managing congenital lung problems and the effects of smoke inhalation, with all updates set to be shared at a major conference in 2020. This knowledge is vital for improving treatments and care for children with lung conditions. Who this helps: This benefits doctors and healthcare providers treating children with respiratory issues.

Plain English
This study looked at how a type of immune cell, called regulatory T cells, can help transplant stem cells from a donor into a fetus late in pregnancy. Researchers found that when they added these regulatory T cells to the transplants, the cells successfully integrated and functioned well without causing harmful immune reactions. This is significant because it means that the window for performing these types of transplants could be extended beyond the typical first trimester, potentially benefiting more fetuses at risk of genetic blood disorders. Who this helps: This helps unborn babies with congenital blood disorders.

Plain English
This study looked at how low oxygen levels in the womb affect brain development in fetuses with congenital heart disease (CHD) using an artificial womb. It found that the oxygen supply was significantly lower in the hypoxic lambs (15.6 mL/kg/min) compared to those with normal conditions (21.6 mL/kg/min), leading to smaller brains and changes in blood flow similar to those seen in human fetuses with CHD. Understanding these effects helps researchers explore new treatments to protect fetal brain development in CHD patients. Who this helps: This benefits patients with congenital heart disease and their families by leading to better treatment options.

Plain English
This study looked at how low oxygen levels before birth affected brain cells in fetal sheep, which can help us understand brain development issues in children with congenital heart disease. Researchers found that in sheep exposed to low oxygen, round-shaped brain cells (microglia) increased from 6% in normal conditions to 33% in low oxygen conditions. This change in brain cells may offer clues about why some children with congenital heart disease have developmental delays. Who this helps: This research benefits doctors and researchers working with children who have congenital heart disease.

Plain English
This study examined how a special system called EXTEND helps premature lambs develop their brains outside the womb. Researchers found that lambs kept in this fluid-filled environment for up to 28 days showed no signs of brain injury and had normal brain development comparable to their full-term peers. This is important because it suggests that this system could help prevent major lifelong disabilities often seen in extremely premature babies. Who this helps: This benefits premature infants and their families by offering a potential solution for improving their neurological outcomes.

Plain English
This study looked at how a special supportive environment for premature lambs, called EXTEND, affects their intestinal development compared to lambs that grow inside their mother. The researchers found that the intestines of the EXTEND-supported lambs showed normal growth and functioning, with healthy structures and movements. However, these lambs had fewer immune cells, which is important for fighting infections. Who this helps: Patients, especially premature infants, may benefit from improvements in their care.

Plain English
Researchers studied a method to improve the success of transplanting blood-producing cells into unborn babies. They used special nanoparticles containing a drug that helps these cells grow and compete better against the baby’s own cells. With this technique, the transplanted cells were stable and functional for up to 24 weeks, which shows promise for treating genetic blood disorders before birth. Who this helps: This helps unborn babies with severe blood disorders.